Astellas Pharma Overview
Valuation check: ALPMY's PEG ratio is 11.23, below the Healthcare sector average of 27.75.
Get informed when a big investor buys or sells
+ Follow11.23
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, ALPMY shows a PEG ratio of 11.23. That is below the Healthcare sector average of 27.75. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 27.75. Astellas Pharma is at 11.23, which is lower that average. That is roughly 59.5% below the sector mean. Use the comparison chart on this page to see how ALPMY stacks up against individual peers as well.
Investors watch ALPMY's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Astellas Pharma's latest reading is 11.23. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Astellas Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 11.23) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 27.75, while ALPMY is at 11.23. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
